A Medicinal Chemist’s Guide to Molecular InteractionsCaterina Bissantz, Martin Ståhl, Bernd Kuhn|Journal of Medicinal Chemistry|2010Cited by 1.7k
A novel antibiotic class targeting the lipopolysaccharide transporterClaudia Zampaloni, Kenneth A. Bradley, Kurt E. Amrein et al.|Nature|2024Cited by 286
A Real-World Perspective on Molecular DesignBernd Kuhn, Martin Ståhl, Wolfgang Guba et al.|Journal of Medicinal Chemistry|2016Cited by 120
<i>In Vivo</i> Efficacy of Meropenem with a Novel Non-β-Lactam–β-Lactamase Inhibitor, Nacubactam, against Gram-Negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection ModelMarguerite L. Monogue, David P. Nicolau, Sara Giovagnoli et al.|Antimicrobial Agents and Chemotherapy|2018Cited by 55
Meropenem–nacubactam activity against AmpC-overproducing and KPC-expressing Pseudomonas aeruginosa in a neutropenic murine lung infection modelTomefa E. Asempa, David P. Nicolau, Ana Motos et al.|International Journal of Antimicrobial Agents|2019Cited by 37